Rivaroxaban CAS:366789-02-8 Mai Kaya na Masana'anta

Rivaroxaban sabon magani ne na hana thrombosis. Sabon magani ne, wanda aka yi ta baki, wanda aka zaɓa kai tsaye don hana factor Xa wanda Bayer Healthcare ta ƙirƙira. EMEA da FDA sun amince da shi don hana thrombosis na jijiyoyin jini a cikin manya bayan an maye gurbin kwatangwalo gaba ɗaya ko kuma an yi masa tiyatar maye gurbin gwiwa gaba ɗaya.

Yi oda ko Nemi Farashi

Cikakken Bayani game da Samfurin

Alamun Samfura

Aikace-aikace da Tasiri

Rivaroxaban yana da halaye na yawan samuwa, nau'ikan cututtuka da ake buƙata, dangantaka mai dorewa tsakanin tasirin magani da allurai, sauƙin shan magani ta baki, da ƙarancin haɗarin zubar jini. Rivaroxaban kuma yana iya hanawa da magance thrombosis na jijiyoyin jini. Ana amfani da shi galibi a asibiti don hana thrombosis mai zurfi na jijiyoyin jini (DVT) da embolism na huhu (PE) a cikin manya marasa lafiya bayan tiyatar maye gurbin kugu da gwiwa. Hakanan ana amfani da shi don hana marasa lafiya da ke fama da fibrillation na atrial marasa valvular daga cerebral apoplexy da noncentral nervous system embolism, kuma yana iya rage haɗarin sake dawowar cututtukan zuciya.

Samfurin Samfuri

Shirya Samfurin:

Ƙarin Bayani:

Tsarin aiki	C19H18ClN3O5S
Gwaji	99%
Bayyanar	Foda fari
Lambar CAS	366789-02-8
shiryawa	25KG
Rayuwar shiryayye	Shekaru 2
Ajiya	A adana a wuri mai sanyi da bushewa
Takardar shaida	ISO.